NewsBite

Minor pharmas could become next prey

The $2.7 billion bid for hospital operator Healthscope has turned the corporate action spotlight on the health care sector, particularly the smaller end of the market.

Brendon Lau
Updated

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

The $2.7 billion bid for hospital operator Healthscope has turned the corporate action spotlight on the health care sector with activity potentially concentrated at the smaller end of the market.

Predators could be spoilt for choice when it comes to hunting for depressed assets. Given the fragile appetite for risk and tight credit conditions, some experts believe bidders would generally be keener on making smaller bolt-on acquisitions that are easier to pull off and integrate.

Loading...

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Read More

Latest In Companies

Fetching latest articles

Most Viewed In Companies

    Original URL: https://www.afr.com/companies/minor-pharmas-could-become-next-prey-20100722-iv3hc